Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
ConclusionsTo support decision making following progression to immunotherapy-based treatment in patients with advanced wild-type lung adenocarcinoma, a consensus document has been developed.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Immunotherapy | Lung Cancer | Spain Health | Taxotere | Toxicology